"Go and see your doctor if you've got anything that you're concerned about – that's what a [doctor] is for," Brian Gemmell ...

The FDA has granted fast-track approval to the drug telisotuzumab vedotin (sold as Emrelis) as a first-of-its-kind treatment for certain people who have non-squamous non-small-cell lung cancer.

The first patient was dosed in the SKYBRIDGE study assessing peluntamig with Tecentriq for advanced small cell lung cancer and neuroendocrine carcinomas. The first patient was dosed in the SKYBRIDGE ...

including standard treatments and clinical trials,” NCCN’s Guidelines for Patients: Non-Small Cell Lung Cancer says. The clinical trial, which was announced as a breakthrough in 2022 ...

Today, the American Lung Association’s LUNG FORCE initiative celebrates Lung Cancer Action Week in California, proclaimed the second week of May, uniting America to stand against lung cancer, the ...